Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct:59:101510.
doi: 10.1016/j.smrv.2021.101510. Epub 2021 Jun 3.

Cognitive dysfunction in central disorders of hypersomnolence: A systematic review

Affiliations
Free article

Cognitive dysfunction in central disorders of hypersomnolence: A systematic review

Marco Filardi et al. Sleep Med Rev. 2021 Oct.
Free article

Abstract

Central disorders of hypersomnolence (CDH) are characterized by excessive daytime sleepiness not related to comorbid sleep or medical disturbances. We systematically examined scientific literature on cognitive functions in patients suffering from CDH. Forty-eight studies proved eligible and were analyzed separately for Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), Idiopathic hypersomnia (IH) and Kleine-Levin syndrome (KLS). Results were grouped into the cognitive domains of attention, memory, executive functions and higher order cognition. Consistent attention impairments emerged in NT1, NT2 and IH patients, with NT1 patients showing the most compromised profile. Memory functions are largely unimpaired in CDH patients except for KLS patients who display memory deficit. Executive functions and higher-order cognition have been assessed in NT1 while they received little-to-no attention in the other CDH. NT1 patients display high performance in executive functions but exhibit a complex pattern of impairment in higher-order cognition, showing poor decision-making and impaired emotional processing. Moreover, NT1 patients show increased creative abilities. Assessing and monitoring cognitive impairments experienced by CDH patients will allow the design of personalized interventions, parallel to pharmacological treatment, aimed at improving daytime functioning and quality of life of these patients.

Keywords: Attention; Cognition; Executive functions; High-order cognitive functions; Idiopathic hypersomnia; Kleine-Levin syndrome; Memory; Narcolepsy type 1; Narcolepsy type 2.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest Giuseppe Plazzi participated in advisory board for UCB Pharma, Jazz pharmaceuticals, Bioprojet and Idorsia, outside the submitted work. The other authors have no potential financial conflict of interest/competing interest to disclose.

Publication types